Yiheng Capital Management, L.P.
In its 13F for Q3 2025 (holdings as of September 30, 2025, filed November 14, 2025), Yiheng Capital Management, L.P. reported 23 stock positions worth $302.3 million. Its top holding was Noah Holdings Ltd.-Spon ADS (NOAH) at 25.8% of the portfolio, followed by Bilibili Inc.-Sponsored ADR (BILI, 13.2%) and New Oriental Educatio-SP ADR (EDU, 9.2%). Compared with Q2 2025, it opened 3 new positions and reduced 5. The biggest buy was a new position in Ultragenyx Pharmaceutical (RARE) and the biggest sale Noah Holdings Ltd.-Spon ADS (NOAH, shares −0%).
- Most Recent 13F
- Q2 2026
- Location
- SAN FRANCISCO, CA
- CIK
- 0001447228
- Portfolio Value
- $302.3M (Q3 2025)
- SEC Filing
- 0001420506-25-003340 ↗ filed Nov 14, 2025
Holdings Value
Holdings 23 stocks · $302.3M
| NOAH Noah Holdings Ltd.-Spon ADS filed as NOAH HLDGS LTD | 25.75% | 6,717,351 | $77.9M | Reduce -0.0% |
| BILI Bilibili Inc.-Sponsored ADR | 13.18% | 1,418,564 | $39.8M | Reduce -26.1% |
| EDU New Oriental Educatio-SP ADR | 9.16% | 521,901 | $27.7M | Reduce -12.7% |
| JD Jd.com Inc.-ADR | 9.11% | 787,413 | $27.5M | No change |
| HTHT H World Group Ltd.-ADR | 5.91% | 457,032 | $17.9M | Reduce -6.5% |
| IVA Inventiva SA - ADR | 5.07% | 2,644,926 | $15.3M | No change |
| RERE Atrenew Inc. | 4.81% | 3,163,117 | $14.6M | No change |
| ACMR Acm Research Inc. Class A | 3.63% | 280,201 | $11.0M | No change |
| VRDN Viridian Therapeutics Inc. | 3.57% | 500,261 | $10.8M | No change |
| AKRO Akero Therapeutics Inc. | 3.00% | 191,076 | $9.1M | Reduce -36.3% |
| KYMR Kymera Therapeutics Inc. | 2.30% | 122,605 | $6.9M | No change |
| DNLI Denali Therapeutics Inc. | 2.26% | 469,981 | $6.8M | No change |
| RARE Ultragenyx Pharmaceutical Inc. | 2.25% | 225,758 | $6.8M | New |
| DBVT DBV Technologies SA-Spon ADR | 2.17% | 656,309 | $6.6M | No change |
| SVCO Silvaco Group Inc. | 1.96% | 1,096,282 | $5.9M | No change |
| PONY Pony AI Inc. | 1.49% | 200,300 | $4.5M | New |
| CLBT Cellebrite Di Ltd. | 1.42% | 231,031 | $4.3M | New |
| TAL Tal Education Group- ADR | 1.15% | 309,240 | $3.5M | No change |
| API Agora Inc.-ADR | 0.67% | 533,547 | $2.0M | No change |
| BEAM Beam Therapeutics Inc. | 0.55% | 69,058 | $1.7M | No change |
| YSG Yatsen Holding Ltd.-ADR | 0.29% | 96,328 | $873K | No change |
| GBIO Generation Bio Co. | 0.21% | 105,524 | $646K | No change |
| TOUR Tuniu Corp.-Spon ADR | 0.10% | 314,437 | $299K | No change |
Options reported separately and not counted above: ALAB puts ($279.5M), JD calls ($63.5M), VSAT puts ($21.6M), BILI calls ($11.2M).
Portfolio Sells Q2 2025 → Q3 2025
Portfolio Buys Q2 2025 → Q3 2025
Options Activity Q2 2025 → Q3 2025
| ALAB Astera Labs Inc. | put | New | 1,427,500 | $279.5M |
| JD Jd.com Inc.-ADR | call | Reduce -88.8% | 1,814,600 | $63.5M |
| ULS Ul Solutions Inc. Class A | put | Sold out | 841,800 | $61.3Mbefore exit |
| PLNT Planet Fitness Inc. Class A | put | Sold out | 270,000 | $29.4Mbefore exit |
| VSAT Viasat Inc. | put | Reduce -50.4% | 735,500 | $21.6M |
| BILI Bilibili Inc.-Sponsored ADR | call | Reduce -95.6% | 400,000 | $11.2M |
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 25 | $227.1M | NOAH, BILI, JD, HTHT, HNGE |
| Q1 2026 | 24 | $230.7M | NOAH, EDU, JD, BILI, HTHT |
| Q4 2025 | 21 | $229.3M | NOAH, BILI, JD, EDU, HTHT |
| Q3 2025 | 23 | $302.3M | NOAH, BILI, EDU, JD, HTHT |
| Q2 2025 | 20 | $276.1M | NOAH, BILI, EDU, JD, HTHT |
| Q1 2025Amended | 21 | $284.5M | NOAH, BILI, EDU, HTHT, JD |
| Q4 2024 | 19 | $451.9M | BILI, NOAH, JD, HTHT, EDU |
| Q3 2024 | 17 | $541.5M | BILI, NOAH, JD, HTHT, EDU |
| Q2 2024 | 20 | $709.1M | BILI, JD, NOAH, HTHT, EDU |
| Q1 2024 | 19 | $696.3M | BILI, JD, NOAH, HTHT, EDU |